WhiteSwell, a Galway medtech firm that raised $78 million (€68.2 million) from investors, has collapsed after its latest round of funding fell through. A provisional liquidator, Aengus Burns of Burns Advisory, has been appointed to wind up the business with a full hearing to take place at the end of this month. WhiteSwell was led by Eamon Brady who previously led two medtech firms that were acquired by Johnson & Johnson and Abbott. The company, founded in 2014, was developing a device for treating heart failure and had completed some clinical trials into the device, with results of its latest…

Want to continue reading?

Celebrate with us – 7 years of The Currency

Unlock full access to The Currency and The Wall Street Journal with an annual membership and receive a FREE Samsonite Spectrolite Briefcase – worth €175 delivered to your door.

Subscribe

Cancel at any time.

Are you already a member? .